A study to see what proportion of patients of acute pancreatitis develop vascular complications and how the vascular complications evolve and what is their outcome

Not Applicable

• Conditions: Health Condition 1: K859- Acute pancreatitis, unspecified

• Registration Number: CTRI/2020/05/025024
• Lead Sponsor: Department of Gastroenterology IPGMER AND SSKM HOSPITA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

All patients with index episode of Acute Pancreatitis presenting upto four weeks after onset of pain and fulfilling the diagnostic criteria for Acute Pancreatitis and having a baseline contrast enhanced Computed Tomogra-phy(CT) of Abdomen performed according to pancreatic protocol at least 5-7 days after onset of pain.

Exclusion Criteria

1.Patients having previous episodes of presumed or diagnosed Acute Pancreatitis with vascular complications

2. Patients diagnosed to have chronic pancreatitis either at evaluation or during the follow up period. Chronic pancreatitis will be diagnosed when a patient has recurrent episodes of upper abdominal pain of pancreatic origin with the following additional criteria9. (A) Pancreatic calcifications. (B) Moderate or marked ductal lesions (ac-cording to the Cambridge classification) (C). Marked and persistent exocrine insufficiency defined as pancreatic steatorrhea markedly reduced by enzyme supplementation. (D) Typical histology of an adequate histological specimen

3. Patients or parents who are not willing to give consent.

4. Patients who are HIV positive

5. Pregnant females

6. Patients of Recurrent Acute Pancreatitis without previous vascular complications

7. Chronic Pancreatitis

8. Any associated malignancy

9. Cirrhosis and established portal hypertension

10.Patients on antiplatelets/ anticoagulants

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome <br/ ><br>Incidence, severity and evolution of vascular complication in acute pancreatitis <br/ ><br>Timepoint: Follow up of 6 months after enrollment <br/ ><br>

Secondary Outcome Measures

Name	Time	Method
Association of vascular complications with the etiology and severity of Acute pancreatitisTimepoint: Follow up of 6 months after enrollment